Company profile for Iktos

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Iktos was founded in 2016 by Quentin Perron, Nicolas Do Huu, and Yann Gaston-Mathé, with the aim of developing an innovative and user-friendly technology platform for deep-learning based de novo drug design, leveraging a proprietary algorithm developed by Quentin and Nicolas who initially wanted to apply to chemistry the deep learning generative models previously used in fields such as image and natural language processing. ...
Iktos was founded in 2016 by Quentin Perron, Nicolas Do Huu, and Yann Gaston-Mathé, with the aim of developing an innovative and user-friendly technology platform for deep-learning based de novo drug design, leveraging a proprietary algorithm developed by Quentin and Nicolas who initially wanted to apply to chemistry the deep learning generative models previously used in fields such as image and natural language processing. Since that time, academic and industry publications in the field of deep learning for drug design have flourished.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
65 rue de Prony 75017 PARIS
Telephone
Telephone
09 73 58 45 48
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/iktos-and-cube-biotech-announce-launch-of-small-molecule-ai-drug-discovery-collaboration-302348215.html

PR NEWSWIRE
10 Jan 2025

https://www.globenewswire.com/news-release/2024/10/17/2964662/0/en/Iktos-appoints-new-Scientific-Advisory-Board-with-world-renowned-AI-and-Drug-Discovery-experts-to-accelerate-the-development-of-novel-therapies.html

GLOBENEWSWIRE
17 Oct 2024

https://www.globenewswire.com/news-release/2024/07/08/2909388/0/en/Iktos-acquires-Synsight-a-life-sciences-technology-company-specializing-in-protein-protein-and-RNA-protein-interactions-targeted-drug-discovery.html

GLOBENEWSWIRE
08 Jul 2024

https://www.globenewswire.com/news-release/2024/06/18/2900136/0/en/Italfarmaco-partners-with-Iktos-on-artificial-intelligence-to-speed-drug-discovery-breakthroughs-for-patients.html

GLOBENEWSWIRE
18 Jun 2024

https://www.globenewswire.com/news-release/2024/05/02/2873854/0/en/Iktos-announces-the-appointment-of-Roman-Fleck-as-Chairman-of-the-Board.html

GLOBENEWSWIRE
02 May 2024

https://www.globenewswire.com//news-release/2024/02/14/2828819/0/en/Iktos-opens-a-subsidiary-in-Japan-and-entrusts-its-management-to-Hideyoshi-Fuji.html

GLOBENEWSWIRE
14 Feb 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty